Navigation Links
Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
Date:4/3/2008

CHARENTON-LE-PONT, France, April 4 /PRNewswire-FirstCall/ -- Essilor is pursuing its external growth strategy in Italy and the United States.

The Group has stepped up its development in Italy with the acquisition of Galileo, a major player in the Italian market. The company sells prescription and stock lenses under its own brand, which is widely recognized in the optics industry and among Italian consumers. Galileo operates a prescription laboratory in Milan and generates EUR13 million in annual revenue.

Essilor of America, a subsidiary of Essilor International, has strengthened its prescription laboratory network in the United States with the acquisition of a majority stake in Empire Optical of California, Inc., located in North Hollywood. A distributor of Varilux(R) lenses, the company has 168 employees and US$23 million in full-year revenue. Empire has major potential for developing Essilor lenses and enables the Group to increase its market share in the nation's most populous state.

Lastly, Essilor of America has also acquired a majority stake in two prescription laboratories: Advance Optical Sales Co., Inc. in Rochester, New York, with revenue of US$6.1 million, and Future Optics Inc. in Jackson, Tennessee, with revenue of US$3.3 million.

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 270 lens finishing laboratories and local distribution networks. The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index. Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF:FP

Investor Relations and Financial Communications

Veronique Gillet - Sebastien Leroy

Phone: +33-1-49-77-42-16

http://www.essilor.com


'/>"/>
SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Essilor : 2007 Results
2. Essilor Enters Bulgarian Market
3. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
4. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
5. PolyRemedy Strengthens Executive Team With Additions of Diane Cooper, PhD, and Joe Coyne
6. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
7. DuPont Strengthens Leading Biotechnology Position with Leadership Changes
8. Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase
9. ESFs EMRC strengthens training course on clinical trials management
10. HEALTHeCAREERS Network Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. Heraeus Strengthens Medical Components Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery ... now accredited by The Joint Commission for chemical dependency and behavioral health services. ... U.S. health care organizations that meet the commission’s rigorous standards. Accreditation by The ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Clinical Plus Coating System for clients that rely on safety and cleanliness. This ... of microorganisms. , Silver has been used for centuries for its antimicrobial properties. ...
(Date:9/20/2017)... ... 2017 , ... Renal Support Network’s annual essay contest celebrates ... The theme “Describe a positive decision that you have made about your healthcare” ... one qualification— to have been diagnosed with chronic kidney disease. This year the ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/31/2017)... -- PM360,s annual Innovations Issue, published in December, ... happening across the industry. Established six years ago, this ... a comprehensive look at the newest and most exciting ... companies, startups, divisions, products, services, and strategies from the ... in this industry wants to do better—in all facets ...
Breaking Medicine Technology: